Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 108 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $330,171 | +17.5% | 27,332 | +15.6% | 0.16% | +28.6% |
| Q1 2022 | $281,000 | -26.6% | 23,646 | 0.0% | 0.13% | -13.1% |
| Q4 2021 | $383,000 | +6.7% | 23,646 | +88.0% | 0.14% | -8.2% |
| Q3 2021 | $359,000 | -22.6% | 12,578 | -8.4% | 0.16% | -17.3% |
| Q2 2021 | $464,000 | +27.8% | 13,728 | +14.5% | 0.19% | +24.8% |
| Q1 2021 | $363,000 | -37.1% | 11,993 | +2.8% | 0.15% | -36.0% |
| Q4 2020 | $577,000 | +105.3% | 11,662 | +59.6% | 0.24% | +62.6% |
| Q3 2020 | $281,000 | -21.7% | 7,309 | -12.0% | 0.15% | -13.5% |
| Q2 2020 | $359,000 | +21.3% | 8,309 | -26.7% | 0.17% | +39.3% |
| Q1 2020 | $296,000 | -27.1% | 11,332 | -12.9% | 0.12% | +84.8% |
| Q4 2019 | $406,000 | – | 13,003 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,757,000 | 9.37% |
| Sofinnova Investments, Inc. | 2,194,278 | $31,641,000 | 1.84% |
| MPM BioImpact LLC | 443,702 | $6,398,000 | 1.52% |
| Artal Group S.A. | 400,000 | $5,768,000 | 0.25% |
| Polar Capital Holdings Plc | 2,531,546 | $36,505,000 | 0.23% |
| ASHFORD CAPITAL MANAGEMENT INC | 101,970 | $1,470,000 | 0.22% |
| Lombard Odier Asset Management (Switzerland) SA | 168,795 | $2,434,000 | 0.21% |
| Soleus Capital Management, L.P. | 87,182 | $1,257,000 | 0.17% |
| Cormorant Asset Management, LP | 150,000 | $2,163,000 | 0.15% |
| Walleye Capital LLC | 437,344 | $6,307,000 | 0.12% |